期刊文献+

红细胞生成素诱导小鼠骨髓纤维化模型的实验研究 被引量:1

A Mouse Model of Myelofibrosis Induced by High Dose of Recombinant Human Erythropoietin
下载PDF
导出
摘要 本研究旨在利用大剂量人重组红细胞生长素(rhEPO)诱导骨髓纤维化(M F)小鼠模型。60只昆明小鼠分为正常对照和EPO诱导组,分别用生理盐水和rhEPO进行腹腔注射,在实验第6、30、60、90、120和150天每组分别处死5只鼠。用细胞分析仪测定外周血白细胞数、血红蛋白(Hb)水平、红细胞平均体积(MCV)、红细胞分布宽度(RDW)和血小板量;用流式细胞术检测骨髓CD34阳性细胞率,称重肝、脾,计算肝、脾系数,利用HE和网状纤维染色分析肝、脾、股骨病理变化;应用高清CT测定股骨皮质厚度、髓腔直径和腰椎密度。结果表明,与正常对照组相比,EPO组各阶段白细胞轻度增高,但无统计学差异(p>0.05);Hb和RDW在第6和30天增高显著(p<0.05);MCV在第6天增高显著(p<0.05);各阶段血小板数降低,在第120和150天差异显著(p<0.05)。EPO组第60天肝肿大明显,肝系数差异显著(p<0.05);各阶段脾肿大,脾系数差异显著(p<0.05)。EPO组各阶段骨髓CD43阳性细胞率显著增高(p<0.05),第150天CT显示股骨皮质增厚,髓腔变窄,密度不均,腰椎密度增高。病理检查显示,EPO组小鼠肝脂肪化和空泡化,脾脏巨核细胞增多,股骨硬化和骨髓纤维组织增多。结论:大剂量rhEPO可诱导小鼠出现M F特有临床和病理特点。本研究对建立新的M F模型和病理研究有重要意义。 Tn order to set up a mouse model of myelofibrosis (MF) induced with high dose recombinant human erythropoietin (rhEPO). 60 mice were collected and divided into EPO and control groups, the former was injected with rhEPO and the latter with normal saline intraperitoneally. 5 mice from each group were executed on day 6,30, 60, 90, 120 and 150 respectively. Their WBC count, Hb level, MCV, RDW and platelet amount were measured by automatic blood cell analyzer; CD34+ cell ratio in bone marrow were analyzed by flow cytometry; liver and spleen coefficients were measured; pathological changes of liver, spleen, femur were observed by HE staining and reticular fibers staining; cortex thickness, femoral canal diameter and lumbar spine density were determined by computerized tomography (CT). The results indicated that as compared with normal control group in EPO induced group, WBC count was increased slightly in whole period, but without statistic significance (p 〉 0.05 ), Hb level and RDW increased at day 6 and 30 significantly (p 〈 0.05 ), MCV increased at day 6 significantly (p 〈 0.05 ), but platelet amount decreased significantly at all time points (p 〈 0.05 ). Most mice in EPO-induced group had hepatomegalia and their liver and spleen coefficient increased significantly at day 60 (p 〈 0.05 ), while most mice had splenomegaly and its coefficient was increased significantly at all time-points (p 〈 0.05 ). CD43+ cell ratio of EPO group increased significantly in whole period (p 〈 0.05). CT scanning displayed femoral cortical thickening, medulla canal narrowing and lumbar spine density increasing at day 150, meanwhile, HE staining and reticular fiber staining showed the fatty degeneration or vacuolization in liver, splenegnly with megakaryocytic proliferation, femur bone marrow fibrosis and osteosclerosis. It is concluded that the mouse induced by high dose of rhEPO displays the myelofibrosis associated with splenic extramedullary hemopoiesis,and this study is useful to establish a practical MF model, and to explore its pathological mechanism.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第4期1043-1047,共5页 Journal of Experimental Hematology
基金 2007年教育部博士点新教师项目基金资助,编号20070023085
关键词 骨髓纤维化 人重组红细胞生长素 动物模型 myelofibrosis (MF) recombinant human erythropoietin animal model
  • 相关文献

参考文献14

  • 1Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol, 2005; 23(33) :8520-8530.
  • 2Le Bousse-Kerdilbs MC, Martyre MC. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol, 1999 ;78(10) :437 -444.
  • 3孟昭婷,高静韬,卢士红,闫昕,李妍涵,杨舟,郑以州.骨髓腔内输注人造血干/祖细胞促进NOD-SCID小鼠体内造血功能的恢复[J].中国实验血液学杂志,2009,17(4):1010-1015. 被引量:2
  • 4Stodtmeister R, Becker H, Cronkite EP, et al. Experimental bone marrow fibrosis in rats following sublethal whole-body x-ray irradiation and bone marrow transfusions as a model of human myelofibrosis. Schweiz Med Wochenschr, 1968 ;98 (42) - 1671 - 1673.
  • 5Wang JC, Tobin MS. Mechanism of extramedullary haematopoiesis in rabbits with saponin-induced myelofibrosis and myeloid meta- plasia. Br J Haematol, 1982 ; 51 (2) :277 - 284.
  • 6Passamonti F, Vanelli L, Malabarba L, et al. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferafive disorders. Haematologica, 2003; 88 (10) :1123 - 1129.
  • 7Massa M, Rosti V, Ramajoli I, et al. Circulating CD34^+, CD133 ^+ , and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid meta- plasia. J Clin Oncol, 2005 ;23(24) :5688 -5695.
  • 8Reagan WJ. A review of myelofibrosis in dogs. Toxicol Pathol, 1993; 21(2) :164 -169.
  • 9Yan XQ, Lacey D, Hill D, et al. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand) : reversal of disease by bone marrow transplantation. Blood, 1996;88(2) :402 -409.
  • 10Vannucchi AM, Bianchi L, Cellai C, et al. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-I(low) mice). Blood, 2002; 100(4):1123-2232.

二级参考文献12

  • 1蔡耘,黄绍良.骨髓腔内注射造血干细胞移植的研究和应用进展[J].中国实验血液学杂志,2006,14(1):179-182. 被引量:7
  • 2Jetmore A, Plett PA, Tong X, et al. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34 ^+ ceils transplanted into conditioned NOD-SCID recipients. Blood, 2002; 99:1585 - 1593.
  • 3Kushida T, Inaba M, Hisha H, et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood, 2001; 97:3292-3299.
  • 4Yahata T, Ando K, Sato T, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD-SCID mice bone marrow. Blood, 2003 ; 101 : 2905 -2913.
  • 5孟昭婷 郑以州.造血干/祖细胞归巢的生物学特性[J].国际输血及血液学杂志,2008,31:331-335.
  • 6Castello S, Podesta M, Menditto VG, et al. Intra-bone marrow injection of bone marrow and cord blood cells : an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol, 2004 ; 32 : 782 - 787.
  • 7Jung CW, Beard BC, Morris JC, et al. Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primates. Exp Hematol, 2007; 35: 1132 -1139.
  • 8Song K, Sun X, Wang J, et al. Role of glycosylphosphatidylinositol-specific phospholipase D in the homing of umbilical cord blood, mobilized peripheral blood and bone marrow-derived hematopoietic stem/progenitor cells. Leuk Res, 2007; 31 : 1701 - 1707.
  • 9Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD-SCID mice by cotransplantation of a second unrelated cord blood uint. Exp Hematol, 2005 ; 33 : 1249 - 1256.
  • 10Wang J, Kimura T, Asada R, et al. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intrabone marrow injection. Blood, 2003; 101:2924 -2931.

共引文献1

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部